Supply Chain | September 10, 2025
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plans
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
Glenmark’s Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials is bioequivalent and therapeutically equivalent to the reference listed drug, Halaven Injection, 1 mg/2 mL (0.5 mg/mL),of Eisai
The new subcutaneous autoinjector for lecanemab offers a self-administered, at-home treatment option for early-stage Alzheimer's disease
Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
Subscribe To Our Newsletter & Stay Updated
